Upward Trajectory: Verona Pharma Plc ADR (VRNA) Posts a Gaine, Closing at 85.54

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

The closing price of Verona Pharma Plc ADR (NASDAQ: VRNA) was $85.54 for the day, up 1.86% from the previous closing price of $83.98. In other words, the price has increased by $1.86 from its previous closing price. On the day, 1.43 million shares were traded.

Ratios:

Our analysis of VRNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.73 and its Current Ratio is at 8.86. In the meantime, Its Debt-to-Equity ratio is 1.08 whereas as Long-Term Debt/Eq ratio is at 1.07.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $100.

On April 21, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $80. On January 10, 2025, ROTH MKM started tracking the stock assigning a Buy rating and target price of $68.ROTH MKM initiated its Buy rating on January 10, 2025, with a $68 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 29 ’25 when Hahn Mark W sold 204,864 shares for $9.33 per share. The transaction valued at 1,911,668 led to the insider holds 12,678,992 shares of the business.

Hahn Mark W sold 162,704 shares of VRNA for $1,513,294 on May 28 ’25. The Chief Financial Officer now owns 12,883,856 shares after completing the transaction at $9.30 per share. On May 27 ’25, another insider, Hahn Mark W, who serves as the Chief Financial Officer of the company, sold 32,432 shares for $9.53 each. As a result, the insider received 308,983 and left with 13,046,560 shares of the company.

Stock Price History:

Over the past 52 weeks, VRNA has reached a high of $86.59, while it has fallen to a 52-week low of $11.79. The 50-Day Moving Average of the stock is 26.84%, while the 200-Day Moving Average is calculated to be 71.86%.

Shares Statistics:

A total of 85.13M shares are outstanding, with a floating share count of 76.70M. Insiders hold about 9.90% of the company’s shares, while institutions hold 76.23% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.